Lyell Competitors and Similar CompaniesClear all
Lyell's competitors and similar companies include Jounce Therapeutics, NovoCure, Agenus and Arvinas.
 NovoCure NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors. |  Agenus Agenus is a clinical-stage immuno-oncology company which focuses on the discovery and development of therapies that engage the body's immune system for patients suffering with cancer. |  Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases. | |||
Founding Date | Founding Date 2018 | Founding Date 2013 | Founding Date 2000 | Founding Date 1994 | Founding Date N/A |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations Cambridge, US HQ | Locations Lexington, US HQ Cambridge, GB Berkeley, US New York, US | Locations New Haven, US HQ | |
Employees | Employees 188 | Employees 1302% increase | Employees 1,32013% increase | Employees 32812% increase | Employees 13329% increase |
Valuation ($) | Valuation ($) 395.4 m | Valuation ($) 101.6 m | Valuation ($) 1.3 b | Valuation ($) 251.9 m | Valuation ($) 1.2 b |
Twitter followers | Twitter followers N/A | Twitter followers 1.1 k | Twitter followers 2.5 k | Twitter followers 2.5 k | Twitter followers 3.1 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 2 | Number of tweets (last 30 days) 8 | Number of tweets (last 30 days) 13 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 6.5 | Average likes per tweet (last 30 days) 13.4 | Average likes per tweet (last 30 days) 2 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 84.62% |
Employee Rating | Employee Rating 3.4 | Employee Rating 4.3 | Employee Rating 3.3 | Employee Rating 3.2 | Employee Rating 4.7 |
Financial | |||||
Revenue (est.) | Revenue (est.) $84.7m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $537.8m (FY, 2022) | Revenue (est.) $98m (FY, 2022) | Revenue (est.) $131.4m (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $104.2m (FY, 2022) | Cost of goods $10.6m (FY, 2022) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $433.6m (FY, 2022) | Gross profit $87.5m (FY, 2022) | Gross profit N/A |
Net income | Net income ($183.1m) (FY, 2022) | Net income ($50.9m) (FY, 2022) | Net income ($92.5m) (FY, 2022) | Net income ($230.7m) (FY, 2022) | Net income ($282.5m) (FY, 2022) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 103m | Total funding raised N/A | Total funding raised $ 171.1m | Total funding raised $ 111.6m |
For sources of this data, please see the company profile
View Company Profiles
Jounce Therapeutics
HQ
Cambridge, US
Employees
130↑ 2% increase
Jounce Therapeutics is a clinical-stage immunotherapy company.
View companyNovoCure
HQ
Saint Helier, JE
Employees
1,320↑ 13% increase
NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.
View companyAgenus
HQ
Lexington, US
Employees
328↑ 12% increase
Agenus is a clinical-stage immuno-oncology company which focuses on the discovery and development of therapies that engage the body's immune system for patients suffering with cancer.
View companyArvinas
HQ
New Haven, US
Employees
133↑ 29% increase
Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.
View company